Iyona Rajkomar Overview
- Firm
- Dawn Biopharma
- Primary Position
-
Managing Partner
- Primary Industry
-
Healthcare
- Active Board Seats
-
5
- Med. Deal Size
-
- Med. Valuation
-
Iyona Rajkomar General Information
Biography
Ms. Iyona Rajkomar serves as Managing Partner at Dawn Biopharma. Previously, Ms. Rajkomar served as Partner at Pontifax Venture Capital, Principal at Advent Life Sciences, Associate at Advent Life Sciences, Investment Manager at Inventages Venture Capital, Strategy Consultant, Pharmaceuticals and Lifesciences at PwC, Equity Research Analyst at Bryan, Garnier & Co, Equity Research Analyst at New York Fitness, and Medical Doctor at St George's University Hospitals NHS Foundation Trust. She also serves as Managing Partner at KKR Dawn Bioventures. She served as Board Member at Antios Therapeutics.
Contact Information
Address
- London
- England, United Kingdom
Iyona Rajkomar Positions (1)
| Firm name | Firm type | Title | Location | Industry | Since |
|---|---|---|---|---|---|
| Dawn Biopharma | Investor | Managing Partner | London, United Kingdom | Acquirer |
Iyona Rajkomar Board Seats (5)
| Company | Industry | Ownership Status | Financing Status | Location | Since |
|---|---|---|---|---|---|
| Abcuro | Drug Discovery | Privately Held (backing) | Venture Capital-Backed | Newton, MA | |
| Adcendo | Drug Discovery | Privately Held (backing) | Venture Capital-Backed | Frederiksberg, Denmark | |
| Adcytherix | Drug Discovery | Privately Held (backing) | Venture Capital-Backed | Marseille, France | |
| Coave Therapeutics | Drug Discovery | Privately Held (backing) | Venture Capital-Backed | Paris, France | |
| RyCarma Therapeutics | Drug Discovery | Privately Held (backing) | Venture Capital-Backed | Ardsley, NY |
Iyona Rajkomar Lead Partner on Deals (11)
Iyona Rajkomar has been the lead partner on 11 deals. Their latest deal was with Adcytherix, a drug discovery company. The deal was made for on 11-Jun-2024.
| Company | Deal Date | Deal Type | Deal Size | Deal Status | Industry | Location |
|---|---|---|---|---|---|---|
| Adcytherix | 11-Jun-2024 | Seed Round | Completed | Drug Discovery | Marseille, France | |
| Amolyt Pharma | 06-Jan-2023 | Completed | Drug Discovery | Lyon, France | ||
| RyCarma Therapeutics | 20-Dec-2021 | Completed | Drug Discovery | Ardsley, NY | ||
| Antios Therapeutics | 03-Nov-2021 | Completed | Drug Discovery | Doylestown, PA | ||
| Amolyt Pharma | 16-Sep-2021 | Completed | Drug Discovery | Lyon, France | ||
| Antios Therapeutics | 09-Apr-2021 | Completed | Drug Discovery | Doylestown, PA | ||
| StrideBio | 11-Mar-2021 | Completed | Drug Discovery | Durham, NC | ||
| Abcuro | 07-Jan-2021 | Completed | Drug Discovery | Newton, MA | ||
| Stargazer Pharmaceuticals | 09-Nov-2020 | Early Stage VC (Series A) | Completed | Drug Discovery | Boston, MA | |
| Amolyt Pharma | 25-Jul-2019 | Later Stage VC (Series A) | Completed | Drug Discovery | Lyon, France |
Iyona Rajkomar Network (178)
Board Members (98)
| Name | Company | Representing | Location | From |
|---|---|---|---|---|
| Ohad Hammer | Adcendo | Pontifax Venture Capital | Frederiksberg, Denmark | |
| Ohad Hammer | Adcytherix | Pontifax Venture Capital | Marseille, France | |
| Abcuro | Self | Newton, MA | ||
| Abcuro | Self | Newton, MA | ||
| Antios Therapeutics | Self | Doylestown, PA |
Portfolio Executives (74)
| Name | Company | Role | Deal date | Location |
|---|---|---|---|---|
| Xavier Preville Ph.D | Adcytherix | Co-Founder, Vice President & Head of Research and Pre-Clinical Development | 11-Jun-2024 | Marseille, France |
| Carsten Dehning | Adcytherix | Co-Founder & Chief Financial Officer | 11-Jun-2024 | Marseille, France |
| Adcytherix | Co-Founder & Chief Executive Officer | 11-Jun-2024 | Marseille, France | |
| RyCarma Therapeutics | Chief Executive Officer & Board Member | 20-Dec-2021 | Ardsley, NY | |
| RyCarma Therapeutics | President & Chief Executive Officer | 20-Dec-2021 | Ardsley, NY |
Fund Team Members (6)
| Name | Investor | Fund | Fund Location |
|---|---|---|---|
| Ohad Hammer | Pontifax Venture Capital | Pontifax Fund IV | Herzliya, Israel |
| Ohad Hammer | Pontifax Venture Capital | Pontifax Fund VI | Herzliya, Israel |
| Pontifax Venture Capital | Herzliya, Israel | ||
| Pontifax Venture Capital | Herzliya, Israel | ||
| Pontifax Venture Capital | Herzliya, Israel |
Iyona Rajkomar Affiliated Funds (3)
| Fund | Investor | Fund Type | Status | Vintage | Size | Dry Powder | IRR | IRR Quartile |
|---|---|---|---|---|---|---|---|---|
| Pontifax Fund V | Pontifax Venture Capital | Venture - General | Closed | 2018 | ||||
| Pontifax Fund IV | Pontifax Venture Capital | Venture - General | Closed | 2015 | ||||
| Pontifax Fund VI | Pontifax Venture Capital | Venture - General | Closed | 2020 |
Iyona Rajkomar FAQs
-
Who is Iyona Rajkomar?
Ms. Iyona Rajkomar serves as Managing Partner at Dawn Biopharma.
-
How much does Iyona Rajkomar typically invest?
Iyona Rajkomar's median deal size is .
-
What is Iyona Rajkomar’s main position?
Iyona Rajkomar’s primary position is Managing Partner.
-
How many active board seats does Iyona Rajkomar hold?
Iyona Rajkomar holds 5 board seats including Abcuro, Adcendo, Adcytherix, Coave Therapeutics, and RyCarma Therapeutics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
